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The zinc-finger transcription factor GATA-3 has received much attention as a master regulator of T helper 2
(Th2) cell differentiation, during which it controls interleukin-4 (IL-4), IL-5, and IL-13 expression. More
recently, GATA-3 was shown to contribute to type 2 immunity through regulation of group 2 innate lymphoid
cell (ILC2) development and function. Furthermore, during thymopoiesis, GATA-3 repressesB cell potential in
early T cell precursors, activates TCR signaling in pre-T cells, and promotes the CD4+ T cell lineage after
positive selection. GATA-3 also functions outside the thymus in hematopoietic stem cells, regulatory
T cells, CD8+ T cells, thymic natural killer cells, and ILC precursors. Here we discuss the varied functions
of GATA-3 in innate and adaptive immune cells, with emphasis on its activity in T cells and ILCs, and examine
themechanistic basis for the dose-dependent, developmental-stage- and cell-lineage-specific activity of this
transcription factor.Introduction
Shortly after its identification in 1990, the zinc-finger transcrip-
tion factor GATA-3 was found to be required both for early
T cell development in the thymus and for differentiation of naive
CD4+ T cells into committed T helper type 2 (Th2) cells (Ting
et al., 1996; Yamamoto et al., 1990; Zhang et al., 1997; Zheng
and Flavell, 1997). The molecular function of GATA-3 has been
most extensively studied in the context of transcriptional regula-
tion of genes encoding the Th2 signature cytokines interleukin-4
(IL-4), IL-5, and IL-13, which are tightly clustered to form the Th2
cytokine locus. Within this locus, GATA-3 has a complex role: it
binds not only to the Il5 and Il13 promoter regions, but also to
Th2-cell-specific DNase I hypersensitive sites (DHSs) that
engage chromatin remodeling machinery allowing GATA-3 to
orchestrate a three-dimensional topography of type II cytokine
transcription (Lee et al., 2006). GATA-3 can repress expression
of other genes, for example Ifng encoding the Th1 signature
cytokine interferon-g (IFN-g), although the mechanism for this
repression remains less clearly understood.
The paradigm of GATA-3 as a central mediator of type II
inflammation was recently extended by the finding that GATA-
3 is also essential for group 2 innate lymphoid cell (ILC2) devel-
opment and Th2 cell cytokine production (Furusawa et al.,
2013; Hoyler et al., 2012; Klein Wolterink et al., 2013; Liang
et al., 2012; Yagi et al., 2014). ILC2s are innate non-T and
non-B lymphoid cells that produce large amounts of IL-5 and
IL-13 upon activation by epithelial-derived proinflammatory
cytokines (Moro et al., 2010; Neill et al., 2010; Saenz et al.,
2010). However, it has become clear that GATA-3 function is
not limited to innate and adaptive lymphocytes that mediate
type II immunity. GATA-3 is also required in several mature
T cell populations as well as in developmental cell fate decisions
during lymphoid development. For example, in addition to con-
trolling Th2 cell differentiation, GATA-3 controls survival and pro-
liferation of CD8+ T cells and is essential for regulatory T (Treg)
cell function (Rudra et al., 2012;Wang et al., 2011, 2013). Beyond
the T cell lineage, GATA-3 is also involved in hematopoietic stemcell (HSC) self-renewal andmaintenance (Fitch et al., 2012; Frelin
et al., 2013; Ku et al., 2012) and repression of B cell commitment
in lymphoid precursors (Banerjee et al., 2013; Garcı´a-Ojeda
et al., 2013). GATA-3 is not needed for classical NK cell develop-
ment, but is important for several specialized subsets of NK cells
(Vosshenrich et al., 2006). In an analogous fashion to its critical
role in early T lymphopoiesis, recent evidence shows that
GATA-3 functions not only in mature ILC2s but also in ILC pre-
cursor cells (Constantinides et al., 2014; Klose et al., 2014; Ser-
afini et al., 2014; Yagi et al., 2014) that give rise to various ILC
populations (reviewed in Spits et al., 2013; Walker et al., 2013).
Thus, GATA-3 is essential in the differentiation and function of
multiple innate and adaptive lymphocytes.
Genome-wide analyses have identified a large number of
GATA-3-binding sites in both active and silent genes in thymo-
cytes and variousmature T cell subsets (Jenner et al., 2009; Kan-
here et al., 2012; Wei et al., 2011), suggesting that GATA-3 can
both activate and repress gene expression. In contrast to the
detailed knowledge of GATA-3 function in transcriptional regula-
tion of Th2 cytokine genes, little is known about mechanisms of
GATA-3-dependent gene regulation in developing T cells and
ILCs. Because GATA-3 has crucial roles in a broad variety of
cell types, it is logical to assume that GATA-3 function is context
dependent. As such, the regulatory output of GATA-3 will be
dictated by its distinct protein-protein interactions in a given
cell type. In this review, we highlight recent reports describing
functional roles for GATA-3 in several hematopoietic cell types
and discuss how genome-wide identification of binding sites
support a model in which GATA-3 is recruited to distinct subsets
of its potential binding sites, in a dose-dependent, develop-
mental-stage-specific, and cell-lineage-specific fashion.
GATA-3 and Its Family Members
In mammals the GATA family of transcription factors consists of
six members, GATA-1 to GATA-6. GATA proteins contain two
N-terminal transactivation domains and two characteristic
Cys4 DNA-binding zinc finger domains, each of which is followedImmunity 41, August 21, 2014 ª2014 Elsevier Inc. 191
Table 1. Interacting Partners of GATA-3
Protein Function Cell Type Reference
CHD4 Chromodomain-helicase-DNA-binding protein 4, ATP-dependent chromatin
remodeler, subunit of the repressive NuRD complex
Th2 Hosokawa et al., 2013
CBP-p300 Histone acetyltransferease (HAT) complex; transcriptional activation Th2 Hosokawa et al., 2013
NuRD Nucleosome remodeling histone deacetylase repression complex;
transcriptional repression
Th2 Hosokawa et al., 2013
Fog1 Friend of GATA-1; zinc-finger transcription factor that inhibits GATA-3
autoactivation and represses Il5 gene transcription and Th2 cell differentiation
naive T cells Zhou et al., 2001
Rog Repressor of GATA (also known as Zbtb32); lymphoid-specific transcription
factor that is rapidly induced in activated T cells and that represses GATA-3-
induced transactivation
activated T cells Miaw et al., 2000
T-bet T-box protein; master regulator of Th1 cell differentiation, essential regulator of
IFN-g expression
Th1 Hwang et al., 2005
Eomes T-box protein eomesodermin, highly homologous to T-bet and expressed in NK
cells and inactivated CD8+ T cells, Th1 cells, and Th2 cells
Th1 Endo et al., 2011
Runx3 Transcription factor that represses CD4 and activates CD8 expression and
promotes Th1 cell differentiation in naive T cells and induces IFN-g
Th1/Th2 Yagi et al., 2010
FoxP3 Master regulator of Treg cell differentiation and function Treg Wang et al., 2011
Smad3 Intracellular signal transducer of TGF-b Th2 Blokzijl et al., 2002
YY1 Yin Yang 1, ubiquitously expressed zinc-finger transcription factor implicated in
long-distance DNA interactions
Th2 Hwang et al., 2013
Fli1 Member of the ETS transcription factor family also known as ERGB T cells Wei et al., 2011
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Reviewby a conserved basic region. The zinc finger closest to the C
terminus mediates binding to the consensus DNA sequence
(A/T)-GATA-(A/G), and the N-terminal zinc finger stabilizes this
binding and physically interacts with the zinc finger coregulator
protein friend of GATA (Fog) (Table 1 and discussed below;
Fox et al., 1998).
GATA factors have pivotal roles during development, as shown
by the fact that disruption of each of the GATA genes (except
GATA-5) inmice results in embryonic lethality.MostGATA factors
show a tissue- and cell-restricted pattern of expression. GATA-1
and GATA-2 are primarily expressed in the hematopoietic
system, whereas GATA-4, GATA-5, and GATA-6 are mostly ex-
pressed in the cardiac, pulmonary, and digestive systems (Bres-
nick et al., 2012; Chlon and Crispino, 2012), although GATA-6 is
also expressed in peritoneal macrophages in which it is required
for proliferative renewal during homeostasis and in response to
inflammation (Okabe and Medzhitov, 2014; Rosas et al., 2014)
(Figure 1). The broad expression of GATA-3 in multiple cell types
is an exception to the rule. There is a functional overlap among
GATA family members: GATA-3 can partially restore erythroid
development in GATA-1-deficient embryos (Tsai et al., 1998)
and GATA-1, GATA-2, GATA-3, and GATA-4 all have the ability
to enhance IL-4 and IL-5 and to inhibit IFN-g production in differ-
entiated T cells (Ranganath and Murphy, 2001).
GATA-1 iscritically involved in thedevelopmentof erythrocytes,
megakaryocytes, mast cells, dendritic cells (DCs), basophils, and
eosinophils (Figure 1). GATA-2 is indispensible for efficient hema-
topoiesis, both for the production and expansion of HSCs in the
embryonic aorta-gonad-mesonephros (AGM) region and for the
proliferation of HSCs in adult bone marrow (Ling et al., 2004).
During erythroid differentiation,GATA-1 andGATA-2manifest dy-
namic reciprocal changes in their expression profiles (see for re-
view Vicente et al., 2012). In addition, a key role for GATA-2 has192 Immunity 41, August 21, 2014 ª2014 Elsevier Inc.beendemonstrated in basophil development andmast cell gener-
ation (Figure 1; Fiedler and Brunner, 2012). Surprisingly, GATA-3
overexpression in early double-negative (DN1) and DN2 but not
DN3 fetal thymocytes that were cultured in the absence of Notch
ligands rapidly and efficiently induced mast cell specification
(Taghon et al., 2007). Mast cell development usually occurs inde-
pendently of GATA-3, but because GATA proteins can induce
their own expression, it is likely that the ability of GATA-3 to
upregulate Gata2 gene expression accounts for the observed
reprogramming of thymocytes into mast cells.
In the hematopoietic system, expression of GATA-3 is
confined to specific lymphocyte populations (Figure 1), as will
be discussed below. GATA-3 is also expressed in various
nonhematopoietic tissues, including adrenal glands, kidneys,
central nervous system, inner ear, hair follicles, skin, and mam-
mary gland. GATA-3-deficient embryos die between embryonic
days 11 and 12 and display internal bleeding, growth retardation,
severe brain and spinal cord deformation, and aberrations in
fetal liver hematopoiesis (Pandolfi et al., 1995). The embryonic
lethality is secondary to noradrenalin deficiency of the sympa-
thetic nervous system, and GATA-3 mutation-induced lethality
is partially averted by feeding catechol intermediates to
pregnant dams (Lim et al., 2000). Haploinsufficiency of GATA3
in man results in an autosomal-dominant developmental disor-
der, referred to as hypoparathyroidism-deafness-renal (HDR)
dysplasia, associated with various heterozygous germline
GATA-3 abnormalities, including nonsense, frameshift, and
missense mutations (Ali et al., 2007). Mutations in GATA3 are
commonly found in human breast cancers and low GATA-3
expression is associated with poor prognosis. GATA-3 is
required for luminal epithelial cell differentiation and commitment
in the mammary gland. Whereas GATA-3 expression sup-
presses lung metastasis, loss of GATA-3 triggers fibroblastic
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Figure 1. Function of GATA Factors in Hematopoietic Development
Overview of hematopoiesis, showing the main lineage commitment steps from HSC to fully maturated and functional blood cells. GATA transcription factors that
are required for these processes are indicated in red: GATA-1 and GATA-2 are important for the development of the erythroid and myeloid cell lineages. In
contrast, GATA-3 is involved only in the lymphoid cell lineage, wherein GATA-3 is crucial for NK cell maturation, for the development of ILCs and T cells, and for the
repression of B cell potential. Abbreviations are as follows: CLP, common lymphoid progenitor; CMP, common myeloid progenitor; HSC, hematopoietic stem
cell; ILC, innate lymphoid cell; NK, natural killer.
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Reviewtransformation and cell invasion (see for review Chou et al.,
2010). Loss of Gata3 is also observed in high-grade invasive
bladder cancer (Higgins et al., 2007).
Members of the GATA family have a highly conserved gene
organization. Two distinct promoters drive lineage- and tissue-
specific expression and alternative first exon usage generates
a series of GATA mRNA isoforms. Regulation of Gata3 expres-
sion is particularly complex and is dictated by individual tissue-
specific enhancers. For example, a kidney enhancer element
has been identified 113 kb 50 to the Gata3 structural gene (Ha-
segawa et al., 2007), whereas a cis-acting element located280
kb 30 to the Gata3 structural gene regulates GATA-3 expression
in the T and NK cell lineage in vivo (Hosoya-Ohmura et al., 2011).
The GATA-3 protein contains a classical nuclear localization
signal motif and its localization between cytoplasm and nucleus
is dependent on phosphorylation of critical serine residues by
mitogen-activated protein kinase (MAPK) p38. MAPK is acti-
vated by T cell receptor (TCR) and IL-33R signaling in T cells
and ILC2s, respectively, which facilitates binding to the nuclear
transporter protein importin-a resulting in nuclear carriage (Frelin
et al., 2013; Furusawa et al., 2013; Maneechotesuwan et al.,
2007). Corticosteroids, which are highly effective in suppressing
allergic airway inflammation, have the capacity to suppress
GATA-3 nuclear import by competing for importin-a and by
inducing MAPK phosphatase-1, an inhibitor of MAPK p38 (Man-
eechotesuwan et al., 2009). Finally, it is known that the acetyla-
tion status of GATA-3 affects its transactivation ability. TheGATA-3 mutant KRR-GATA-3 is hypoacetylated and shows
hypomorphic functions, resulting in reduced T cell survival and
altered lymphocyte homing (Yamagata et al., 2000).
GATA-3 in Th2 Cell Differentiation
The role of GATA-3 in transcriptional regulation of themurine Th2
cytokine locus is well understood (Figure 2). This150 kb region
contains Il4, Il5, and Il13, as well as a locus control region (LCR)
that is crucial for appropriate Th2-specific cytokine expression
and is located at the 50 end of the interspersed Rad50 gene, en-
coding a ubiquitously expressed DNA repair protein (Spilianakis
and Flavell, 2004). GATA-3-mediated gene regulation and chro-
matin remodeling in the Th2 cytokine locus represents a model
for understanding the molecular mechanisms of type II immune
responses.
Initiation of Th2 Cell Differentiation and Inhibition of Th1
Cell Differentiation
Multiple distinct Th cell subsets (Th1, Th2, Th9, Th17, Th22,
follicular T helper [Tfh], and Treg cells), characterized by unique
cytokine production and transcription factor profiles, have been
described (see for recent review Vahedi et al., 2013).
Th2 cells control helminth infections and allergic immune
responses and are characterized by the expression of the proin-
flammatory cytokines IL-4, IL-5, and IL-13. The initiating signals
that drive Th2 cell differentiation have been the subject of intense
investigation and include IL-4, which induces phosphorylation
and activation of STAT6, which in turn enhances GATA-3Immunity 41, August 21, 2014 ª2014 Elsevier Inc. 193
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Figure 2. GATA-3-Mediated Regulation of the Th2 Cytokine Locus
(A) GATA-3 binds to the Il5 and Il13 promoter regions and to the Il13 HS1-CGRE region (Kishikawa et al., 2001; Tanaka et al., 2011; Zhang et al., 1998). GATA-3
can also bind to a regulatory element in the first intron of the Il4 gene (Tykocinski et al., 2005). GATA-3 helps establish long-range chromatin changes in the
cytokine locus during Th2 cell differentiation, including the acquisition of four specific DHS sites: the HSII-intronic enhancer (IE), HSIII, HSVa, and HSV, whereby
HSII-IE is crucial in GATA-3-mediated activation of Il4 (Agarwal and Rao, 1998; Antebi et al., 2013; Lee et al., 2000; Yamashita et al., 2004). HSII, controlled by
GATA-3, is strongest of the known Il4 enhancers in Th2 cells (Kishikawa et al., 2001; Tanaka et al., 2011; Zhang et al., 1998). In the intergenic regulatory region
CNS-1 located between the Il4 and Il13 genes, two additional Th2-cell-specific DHS sites HSS1 and HSS2 are occupied by GATA-3 in vitro (Takemoto et al.,
2000). GATA-3 also binds to RHS5 and RHS7 in the LCR located within Rad50 (Lee et al., 2003) in a STAT6-dependent manner (Lee and Rao, 2004). Additional
nuclear factors that have been shown to bind in the Th2 locus are indicated (see text).
(B) Schematic representation of the Th2 locus in naive T cells (left) and in polarized Th2 cells (right). In naive T cells, the promoters for the Th2 cytokine genes are in
close spatial proximity. During Th2 cell differentiation, activated STAT6 and Notch signaling induce GATA-3 upregulation, leading to the participation of the LCR
and CNS1 elements in this ‘‘poised’’ chromatin core configuration, allowing for high transcription of IL-4, IL-5, and IL-13, which is dependent on the presence of
CTCF (Ribeiro de Almeida et al., 2009).
Abbreviations are as follows: CGRE, conserved GATA-3 response element; CNS1, conserved noncoding region; CTCF, CCCTC-binding factor; DHS, DNaseI
hypersensitive site; Il, interleukin; IRF4, interferon regulatory factor 4; LCR, locus control region; RBPjk, recombination-signal-binding protein for immunoglobulin
Jk region; Runx3, Runt-related transcription factor 3; Satb1, special AT-rich sequence-binding protein-1; STAT, Signal Transducer and Activator of Transcription;
YY1, Yin Yang 1.
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Reviewexpression via distal and proximal Gata3 promoters and an
upstream conserved regulatory region (Scheinman and Avni,
2009). GATA-3 is necessary and sufficient for Th2 cytokine
gene expression in T helper cells (Zhang et al., 1997; Zheng
and Flavell, 1997). Once induced, GATA-3 upregulates its
own expression, either directly (Ouyang et al., 2000) or via
the transcription factor Dec2 (Yang et al., 2009). GATA-3 is
essential for the differentiation of naive T cells to Th2 cells, as
well as for the activation of already established Th2 cells (Pai
et al., 2004; Zhu et al., 2004). The induction of GATA-3 by the
IL-4-STAT6 axis in differentiating Th2 cells, however, raises
the paradox that IL-4 is essential for the generation of the cell
type that is its major producer. The initial source of IL-4 that
directs the Th2 cell response remains unclear. Although a range
of cell types can produce IL-4, Th2 cell responses can be
generated when IL-4 is exclusively produced by T cells or
when mice lack functional IL-4R signaling, arguing against a
requisite role for an external source of IL-4 (Jankovic et al.,
2000; Schmitz et al., 1994).
Other pathways have been implicated in the initial production
of IL-4. TCR triggering in naive T cells induces GATA-3 and IL-4
upregulation (Grogan et al., 2001; Yamane et al., 2005) and IL-2
secretion that in turn activates STAT5a in T cells (Lin and Leo-
nard, 2000). STAT5a can bind to the DNase hypersensitive sites
(DHSs) HSII and HSIII in the Il4 locus (Figure 2), and high STAT5a
activity can cooperate with GATA-3 to induce Th2 cell differenti-
ation (Cote-Sierra et al., 2004). Several studies showed that
GATA-3 and IL-4 expression can be directly regulated by Notch
signaling in activated T cells (Amsen et al., 2007; Fang et al.,
2007). The role of Notch signaling in the innate and adaptive
immune system has recently been reviewed (Radtke et al.,
2013). Differentially expressed Notch ligands on DCs are able
to instruct differentiation of naive CD4 T helper cells: Delta-like
(DLL) and Jagged ligands induce Th1 and Th2 cell differentiation,
respectively (Amsen et al., 2004). Notch signaling induces Th2
cell differentiation (1) by directly activating the upstream Gata3
gene promoter and (2) by regulating Il4 gene transcription
through activation of a 30 enhancer. Both of these events are
dependent on a nuclear complex that contains recombination-
signal-binding protein for immunoglobulin Jk region (RBPjk). In
the absence of GATA-3, Notch no longer induces Th2 cells but
instead induces Th1 cell differentiation. Mice lacking RBPjk or
the Notch1 and Notch2 receptors fail to generate robust Th2
cell responses to parasite antigens (Amsen et al., 2007). There-
fore, it can be concluded that the Notch signaling pathway is a
STAT6-independent pathway that is crucial for Th2 cell induction
via GATA-3. Although high amounts of exogenous IL-4 can
induce normal Th2 cell differentiation in the absence of Notch
signaling (Amsen et al., 2007; Ong et al., 2008; Tu et al., 2005),
it is likely that under physiological conditions, Notch signaling
and IL-4R signaling synergize to promote Th2 cell responses
via the activation of GATA-3.
GATA-3 and Notch signaling are also required for efficient Th9
cell development. Th9 cells produce IL-9 and can differentiate
from naive T cells or Th2 cells under the influence of IL-4, IL-9,
and TGF-b (Kaplan, 2013). It has been shown that IL-9R expres-
sion is regulated by GATA-3 (Wei et al., 2011). Conditional dele-
tion of Notch1 and Notch2 led to decreased IL-9 production
in Th9 cell cultures, and the Notch ligand Jagged2—but notDelta-like 1—induced IL-9 in cells cultured with TGF-b alone
(Elyaman et al., 2012).
Whereas Th2 cells substantially upregulate GATA-3 levels
during development, Th1 cells express very low amounts of
GATA-3 (Ouyang et al., 1998; Usui et al., 2006; Zhang et al.,
1997; Zheng and Flavell, 1997). During Th2 cell differentiation,
GATA-3 inhibits T-bet function and IFN-g expression. Moreover,
GATA-3 suppresses Th1 cell development by downregulating
STAT4 and IL-12Rb2 chain expression (Ouyang et al., 1998;
Usui et al., 2006). This was supported by genome-wide analyses
demonstrating that GATA-3-deficient Th2 cells have increased
expression of STAT4 and IL-12Rb2 mRNA (Wei et al., 2011).
Nevertheless, recent data show that Th1 and Th2 cell differenti-
ation is not mutually exclusive (as previously thought); stable and
functional GATA-3+T-bet+ T cells that produce both IL-4 and
IFN-g are generated in vitro and in vivo in parasite and lympho-
cytic choriomeningitis virus (LCMV) infection (Antebi et al.,
2013; Fang et al., 2013; Hegazy et al., 2010; Peine et al., 2013).
These GATA-3+T-bet+ T cells support both Th1- and Th2-cell-
mediated immune responses but cause less immunopathology
compared with committed T-bet+ Th1 or GATA-3+ Th2 cells,
suggesting a regulatory role for these GATA-3+T-bet+ T cells.
These studies are consistent with the notion of T helper cell flex-
ibility and adaption depending on the characteristics of invading
pathogens. Moreover, evidence is now emerging for frequent
coexpression of the Th cell signature transcription factors
GATA-3, T-bet, RORgt, Bcl6, or FoxP3 in specialized CD4+
T cell subtypes, challenging the paradigm of stable T helper
cell subsets defined by the expression of a single ‘‘master regu-
lator’’ (Oestreich and Weinmann, 2012). As such, T helper cell
differentiation appears quite diverse and perhaps less stable
compared with developmental cell-fate decisions that accom-
pany lineage commitment, e.g., to the B or T lymphocyte lineage.
GATA-3 and the Th2 Cytokine Locus
GATA-3 binds directly to the Il5 and Il13 promoters, as well as to
a binding site in the first intron of the Il4 gene (Figure 2). In addi-
tion, GATA-3 plays a crucial role in establishing long-range chro-
matin interactions, because it binds to almost all DHSs in the
locus that Th2 cells acquire during their differentiation from naive
T cells, including DHSs in the LCR, as well as four DHSs crucial
for activation of Il4 (Tanaka et al., 2011). GATA-3 can induce the
latter DHSs in Th1 cells, which clearly demonstrates that GATA-3
is associated with chromatin remodeling activity (Lee et al.,
2000). More recently, chromatin immunoprecipitation coupled
with next generation sequencing (ChIP-seq) experiments
showed that in Th2 cells, genomic regions surrounding the
GATA-3 binding sites in Il4 and Il13 are associated with acti-
vating H3K4 methylation but lack extensive repressive H3K27
trimethylation. In contrast, GATA-3 binding sites in the Tbx21
and Ifng loci are associated with H3K27 trimethylation in Th2
cells (Chang and Aune, 2007; Wei et al., 2011). The finding that
deletion of Gata3 resulted in decreased H3K4 dimethylation at
specific sites in the Th2 cytokine locus and decreased H3K27 tri-
methylation around its binding sites in the Tbx21 and Ifng loci
showed that GATA-3 mediates gene activation and repression
by chromatin remodeling (Wei et al., 2011). Although T-bet is
not expressed by Th2 cells, T-bet and GATA-3 are coexpressed
in polarized human and mouse Th1 cells. Interestingly, ChIP-seq
experiments showed that many of the T-bet and GATA-3 bindingImmunity 41, August 21, 2014 ª2014 Elsevier Inc. 195
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2009; Kanhere et al., 2012), as discussed below.
Chromosome conformation capture (3C) studies show that the
promoters for the Th2 cytokine genes are in close spatial prox-
imity in various cell types, and in CD4+ T cells specifically the
LCR participates in this ‘‘poised’’ chromatin core configuration
(Spilianakis and Flavell, 2004). GATA-3 and STAT6 have the
capacity to directly remodel the LCR (Lee and Rao, 2004) and
are essential for the establishment or maintenance of these
long-range interactions, but additional nuclear factors have
been implicated in the 3D organization of the Th2 cell locus.
These include Th2-cell-specific transcription factors involved in
Il4 gene regulation, such as interferon regulatory factor 4
(IRF4), nuclear factor of activated T cells NFATc2, and c-Maf,
but also general chromatin organizers, such as special AT-rich
binding protein 1 (SATB1), Yin Yang1 (YY1), CCCTC-binding fac-
tor (CTCF), and cohesin (Figure 2; Barski et al., 2007; Cai et al.,
2006; Hwang et al., 2013; Parelho et al., 2008). Further studies
are required to elucidate the exact mechanisms by which
GATA-3 contributes to the formation of chromatin loops in the
Th2 cytokine locus.
In addition to Th2 cells, diverse myeloid cells, including mast
cells, basophils, and eosinophils, are potent producers of IL-4,
IL-5, and IL-13 in vivo. The finding that GATA-1 and GATA-2
bindHSII in the Il4 locus inmast cells (Kwan et al., 2005) indicates
that in type II immunity, GATA-3 function in lymphoid cells is, at
least partly, substituted by GATA-1 and/or GATA-2 in myeloid
cells.
GATA-3 in T Cell Development
Because GATA-3 plays critical roles in several tissues and dele-
tion ofGata3 results in embryonic lethality in mice (Pandolfi et al.,
1995), analysis of GATA-3 function in immune development
has been challenging. However, the use of diverse technical
approaches (including blastocyst complementation, fetal liver
hematopoietic stem cell reconstitution, and conditional gene tar-
geting) has provided important clues as to how GATA-3 func-
tions during the various stages of T cell development.
One dramatic result of GATA-3 deletion is the complete
absence of T cell development (Hendriks et al., 1999; Hosoya
et al., 2009; Ting et al., 1996). In the thymus, the T cell program
is initiated by differentiation of early thymic progenitors (ETPs)
derived from multipotent hematopoietic precursors in the bone
marrow (Rothenberg and Taghon, 2005). Thymopoiesis requires
several regulatory pathways for early thymocyte differentiation,
including activation of the Notch1 receptor (Pui et al., 1999;
Radtke et al., 1999) by its ligand delta-like 4 expressed on thymic
epithelial cells (Hozumi et al., 2008; Koch et al., 2008). Notch1
triggering initiates and sustains the T cell program via activation
of its transcription factor targets Tcf1 and Bcl11b (Chi et al.,
2009). GATA-3 is also upregulated at this stage, although it is
not clear whether this event is Notch dependent. As such, the
interrelationship between Notch1 and GATA-3 pathways re-
mains unclear. Without Notch1 signals, ETPs do not develop
and thymic progenitors can be diverted into the B cell pathway
(Feyerabend et al., 2009; Sambandam et al., 2005; Wilson
et al., 2001). This Notch1-mediated repression of B cell develop-
ment also involves GATA-3, as shown by the fact that GATA-3-
deficient pro-T cells retain a latent B cell potential despite active196 Immunity 41, August 21, 2014 ª2014 Elsevier Inc.Notch1 triggering (Figure 3; Garcı´a-Ojeda et al., 2013). This is not
the case with pro-T cells deficient for the Notch1 targets Tcf1 or
Bcl11b (Li et al., 2010; Weber et al., 2011), and thus GATA-3
appears unique in its ability to ‘‘seal’’ Notch1-induced T cell
commitment (Rothenberg, 2013). The mechanism by which
GATA-3 represses the B cell program is unknown, but it is strik-
ing that repression of GATA-3 by the transcription factor early B
cell factor-1 (Ebf1) is a critical component of normal B cell devel-
opment (Banerjee et al., 2013). In the absence of Ebf1, lymphoid
progenitors exhibit increased T cell lineage potential associated
with increased Gata3 gene transcription (Banerjee et al., 2013).
Ebf1 ablation can divert lymphoid precursors into the ILC
pathway as well (Nechanitzky et al., 2013). As such, the relative
balance between GATA-3 and Ebf1 pathways critically deter-
mines the B versus T cell or ILC fate decision.
Using Lck-Cre transgenic Gata3-floxed mice to ablate
GATA-3 expression in early DN cells, it was established that
GATA-3 is critical for b-selection (Figure 3) and thus for the gen-
eration of T cell receptor (TCR-b)-expressing DN4 thymocytes
(Pai et al., 2003). This is consistent with findings in GATA-3 re-
porter mice that demonstrate upregulation of GATA-3 during
pre-TCR-mediated b-selection (Hendriks et al., 1999). Continued
Notch1 triggering is also required for this transition (Bender et al.,
2004; Wolfer et al., 2002), which again suggests a close relation-
ship between Notch1 and GATA-3 pathways at this juncture.
Using ChIP-seq technology and expression profiling in devel-
oping thymocytes, GATA-3 binding was detected at 1,500 loci
with marked differences in GATA-3 occupancy between early
and later stages of T cell development (Wei et al., 2011; Zhang
et al., 2012). In fact, GATA-3 binding sites did not show signifi-
cant similarities between DN1 and DP cells, but rather binding
was particularly enriched at ‘‘stemness’’ genes and ‘‘T cell iden-
tity’’ genes, in these respective stages (Zhang et al., 2012).
These analyses suggest that GATA-3 is involved in the control
of the expression of many genes that play a crucial role in
T cell development, including key transcription factors, Notch1
and Notch2, TCR components, and the RAG enhancer. Because
in DN thymocytes GATA-3 occupancy of regulatory elements in
Cd3d, Rag1, Rag2, and Zbtb7b loci preceded their expression,
GATA-3-mediated chromatin remodeling may function to pre-
pare loci for interactions with nuclear factors at later stages of
T cell development.
Conditional ablation of GATA-3 at later stages of T cell
development (at the DP stage, using CD4-Cre transgenic
Gata3-floxed mice) demonstrates the necessity of GATA-3 for
promoting CD4+ lineage choice (Pai et al., 2003). In the absence
of GATA-3, differentiation of the CD4+ lineage is blocked before
CD4/CD8 commitment, because MHC class II-restricted GATA-
3-deficient thymocytes are redirected to the CD8+ T cell lineage,
albeit inefficiently (Wang et al., 2008). In this context, GATA-3 is
required for the expression of the transcription factor ThPOK,
which promotes CD4+ lineage differentiation (He et al., 2005;
Sun et al., 2005). The finding that enforced ThPOK expression
does not rescue CD4+ lineage differentiation of GATA-3-defi-
cient thymocytes indicates that GATA-3 also acts as a key
CD4+ lineage differentiation factor, independently of its capacity
to induce ThPOK (Wang et al., 2008). Expression of GATA-3 is
induced by TCR signaling during positive selection at the DP
stage, and because GATA-3 enhances TCR upregulation, it is
Figure 3. GATA-3 Has Multiple Roles in ILC and T Cell Development and Function
HSC-derived CLPs give rise to both adaptive and innate lymphoid cells. ILC development (top) mirrors T cell development (bottom). Developmental steps or
cellular functions that absolutely require GATA-3 are indicated. These include the generation of a common ILC precursor and the differentiation into thymic NK
cells and ILC2s, as well as NK cell maturation. GATA-3 represses B cell potential and is crucial in various stages of T cell development. In addition, GATA-3 is
important for the function of CD8+ T cells, Treg cells, and Th2 cells, as indicated. T effector cells and ILC subsets are grouped according to their ability to produce
different cytokines. Abbreviations are as follows: CLP, common lymphoid progenitor; CTL, cytotoxic T lymphocyte; HSC, hematopoietic stem cell; IFN, interferon;
IL, interleukin; ILC, innate lymphoid cell; iNK, immature NK cell; mNK, mature NK cell; NK, natural killer cell; NKT, natural killer T cell; P, progenitor; TGF,
transforming growth factor; Th, T helper cell; Treg, regulatory T cell.
Immunity
Reviewlikely that GATA-3 establishes a positive-feedback loop that
increases TCR surface expression in developing CD4-lineage
cells (Herna´ndez-Hoyos et al., 2003; Ling et al., 2007). Accord-
ingly, GATA-3 binds strongly to the Tcra, Tcrb, Cd3d, and
Cd3g loci and expression of CD3d andCD3εmRNA is decreased
in GATA-3-deleted CD69+ DP cells. Although it has been sug-
gested that Notch activity directly influences CD4/CD8 lineage
commitment, it now seems that DP cells have very low levels
of Notch signaling and that Notch does not play a direct role in
lineage commitment (Laky and Fowlkes, 2008; Radtke et al.,
2013).
Development of CD8+ SP thymocytes is not affected by lack of
GATA-3. However, peripheral mature naive CD8+ T cells consti-
tutively express GATA-3, albeit to lower levels than found in
CD4+ T cells, and expression is upregulated by TCR activation
and cytokine signaling. GATA-3 is important in CD8+ T cells
because it controls proliferation by regulating c-Myc, but it is
dispensable for IFN-g production (Figure 3; Wang et al., 2013).
GATA-3-deficient CD8+ T cells manifest defective long-term
maintenance, which is attributed to lower IL-7R expression. By
contrast, GATA-3 expression does not appear to be critical forthe response to IL-7 in thymocytes. This is inferred from the
finding that in GATA-3-deficient mice, CD8+ SP thymocytes
develop normally, although IL-7R signaling is essential for posi-
tively selected thymocytes to express the transcription factor
Runx3 to specify CD8-lineage choice and promote CD8+ SP
differentiation (Park et al., 2010).
Although GATA-3 is required for multiple stages of T cell
lineage development (Figure 3), an additional role for GATA-3
in prethymic lympho-hematopoietic progenitor cells is as yet
unclear. HSCs express GATA-3 (Ku et al., 2012), although early
reports found that absence of GATA-3 did not affect the
generation, maintenance, or self-renewal of HSCs in fetal and
adult mice (Buza-Vidas et al., 2011; Hosoya et al., 2009; Kan-
here et al., 2012). In contrast, it was recently shown that
Gata3 deletion enhances expansion of long-term multipotent
HSCs, consistent with a role for GATA-3 as an autonomous
regulator of the balance between HSC self-renewal and
differentiation (Frelin et al., 2013). Although in the absence of
Gata3 the production of functional definitive HSCs in the em-
bryonic AGM region is impaired, this is largely independent of
a cell-intrinsic role of GATA-3 and secondary to abnormalitiesImmunity 41, August 21, 2014 ª2014 Elsevier Inc. 197
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2012).
GATA-3 in ILC Development and Function
Recent work has demonstrated that GATA-3 serves as a central
regulator of ILC development and function (Figure 3). ILCs
contribute to the first-line immune defense against invading
pathogens and have the capacity to promptly produce large
amounts of proinflammatory cytokines, prior to the generation
of adaptive immunity. ILCs have been categorized into three
major groups, based on transcription factor dependency and
cytokine production profiles, which strikingly mirror the various
T helper cell subsets (Spits et al., 2013). Group 1 ILCs (or ILC1s)
consist of NK cells and other IFN-g-producing innate lympho-
cytes that express T-bet. ILC1s have been shown to play a ma-
jor role in the defense against viruses, intracellular bacteria, and
protozoa (Klose et al., 2014; Kupz et al., 2013; Orr and Lanier,
2010). ILC2s secrete IL-5 and IL-13 in response to stimulation
with the cytokines IL-25, IL-33, or thymic stromal lymphopoietin
(TSLP). ILC2s are important in the immune response against
helminths but are also associated with allergic airway inflamma-
tion and hyperreactivity and maintenance of epithelial barrier
integrity during influenza infection (see for review Li and Hen-
driks, 2013). Group 3 ILCs (ILC3s) include several phenotypi-
cally distinct cells that express and require the transcription
factor RORgt for their development and for production of IL-
17A and IL-22. ILC3s are enriched at mucosal sites and appear
to regulate barrier function and epithelial cell homeostasis
(Walker et al., 2013).
ILC1s
Several transcription factors drive bone-marrow- and tissue-
resident NK cell development from lymphoid precursors,
including the T-box factors T-bet (encoded by Tbx21) and
eomesodermin (Eomes), nuclear-factor interleukin-3 related
(Nfil3), and GATA-3 (reviewed in Vosshenrich and Di Santo,
2013). Gata3 ablation affects the development of mature
CD11b+ splenic NK cells and reduces their capacity to produce
IFN-g (Samson et al., 2003). In the thymus, GATA-3 deletion ab-
lates the generation of IL-7Ra+ NK cells (Vosshenrich et al., 2006)
and more recent results show that GATA-3 is also critical
for the development of a particular subset of CD49a+Eomes
NKp46+NK1.1+ ILC1s in the gut (Klose et al., 2014) but not in
the liver (Sojka et al., 2014). This differential impact of GATA-3
deletion on diverse NK cell subsets suggests distinct develop-
mental pathways for conventional and tissue-resident NK cells
(Figure 3; Daussy et al., 2014; Di Santo and Vosshenrich, 2006;
Klose et al., 2014). Consistent with this hypothesis, a bone
marrow PLFZ+GATA-3+ ILC precursor was described that can
develop into CD49a+ hepatic but not conventional NK cells
(Constantinides et al., 2014). The signals that generate these
apparently distinct ILC precursors from CLP and their capacity
to promote NK cell development in the bone-marrow- versus
tissue-specific sites remains an area of active research.
Recent work has demonstrated that other IFN-g-producing
NK1.1+ cells are present in mucosal sites in humans (Bernink
et al., 2013) and in mice (Fuchs et al., 2013; Klose et al., 2014).
These ILC1 subsets require the transcription factors T-bet,
Nfil3, and GATA-3 for their generation and are phenotypically
distinct from conventional NK cells that express NKp46,198 Immunity 41, August 21, 2014 ª2014 Elsevier Inc.CD49a, IL-7Ra, and CD27, but not CD11b. These ILC1 subsets
seem to be an important source of IFN-g and TNF-a in both the
intestinal epithelial layer and the lamina propria under steady-
state conditions and during intestinal inflammation (Fuchs
et al., 2013; Klose et al., 2014). The molecular mechanism
through which GATA-3 contributes to ILC1 development or
whether its maintained expression is needed for functional attri-
butes is unclear.
ILC2s
GATA-3 plays an essential role in ILC2 development in mice
(Furusawa et al., 2013; Hoyler et al., 2012; Klein Wolterink
et al., 2013; Yagi et al., 2014) and man (Mjo¨sberg et al., 2012)
(Figure 3). ILC2s are generated from CLPs in vivo (Wong et al.,
2012; Yang et al., 2011) and alterations in Gata3 gene dosage
positively correlates with ILC2 development from CLPs in vitro
(Klein Wolterink et al., 2013), suggesting that GATA-3 transcrip-
tional activity is a major determinant of ILC2 cell fate in uncom-
mitted lymphoid precursors. Accordingly, bone marrow and
lung ILC2 homeostasis in naive mice correlates in vivo with
Gata3 gene copy number (Klein Wolterink et al., 2013). The tran-
sition from CLP to ILC2 is associated with upregulation of the
transcription factors inhibitor of DNA-binding 2 (Id2) and
RORa, both of which are essential for ILC2 differentiation (Halim
et al., 2012; Wong et al., 2012). Although the gene encoding Id2,
which is involved in the development of all known ILC lineages
(Moro et al., 2010; Yokota et al., 1999), is occupied by GATA-3
in early thymocyte precursors (Zhang et al., 2012), inactivation
of GATA-3 in mature ILC2s did not affect the expression of
Id2 or RORa (Yagi et al., 2014). In vitro generation of ILC2s
from CLPs is dependent on Notch signaling (Wong et al., 2012;
Yang et al., 2011), although it remains to be demonstrated
whether ILC2 development in vivo requires canonical Notch
signaling. Nevertheless, certain parallels between ILC2 develop-
ment and early T cells are striking: Notch1, GATA-3, and Tcf1 are
critical for ILC2 and T cell development (Yang et al., 2013), with
Tcf1 being a Notch1-induced target for T cell specification
(Weber et al., 2011) that probably serves a similar role in ILC2
generation.
In mature ILC2s, GATA-3 controls cell activation and function,
including IL-5 and IL-13 cytokine secretion, cytokine responsive-
ness (IL-25 and IL-33 receptors), and production of amphiregu-
lin, an epidermal growth factor family protein essential for airway
epithelium integrity (Hoyler et al., 2012; Klein Wolterink et al.,
2013; Liang et al., 2012; Monticelli et al., 2011; Yagi et al.,
2014). The finding that ILC2 effector function directly correlates
with Gata3 gene expression suggests that GATA-3 modulation
impacts pathological conditions that involve dysregulation of
type II immunity. This notion gains support from genome-wide
association studies showing a significant association of the
Il33 and Il1Rl1 (encoding the IL-33R subunit T1ST2) loci with
asthma in human and the increased susceptibility to allergic
airway inflammation observed in mice with enforced expression
of GATA-3 in T cells and ILC2s (KleinJan et al., 2014). In mouse
models of allergic lung inflammation, ILC2s along with classical
Th2 cells are major producers of IL-5 and IL-13 that orchestrate
and amplify allergic inflammatory events in asthma (KleinWolter-
ink et al., 2012). Moreover, ILC2-derived IL-13 can promote
migration of activated lung DCs that drive differentiation of naive
T cells into Th2 cells (Halim et al., 2014).
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IL-13 cytokine production both in ILC2s and in Th2 cells, which
synergize in type II immunity and are activated through different
mechanisms and with different kinetics.
ILC3s
ILC3s are a heterogeneous population and include CCR6+
lymphoid tissue inducer (LTi) cells that are needed for lymphoid
tissue organogenesis in lymph nodes and Peyer’s patches dur-
ing fetal life and for postnatal formation of intestinal lymphoid
clusters (van de Pavert et al., 2014). Moreover, adult CD4+
ILC3s that can be found in secondary lymphoid tissues and in
mucosal sites produce IL-17A and IL-22 that can contribute to
immune defense (Takatori et al., 2009). Another subset of
ILC3s that express the NK cell receptor NKp46 is noncytotoxic
and produces IL-22 but not IFN-g (Cella et al., 2009; Sanos
et al., 2009; Satoh-Takayama et al., 2008). NKp46+ ILC3s are
CCR6, are found primarily in the intestinal lamina propria, and
cross-talk with epithelial cells to stimulate cell proliferation and
production of antimicrobial peptides that regulate communities
of commensal bacteria (Satoh-Takayama et al., 2008; Sonnen-
berg et al., 2012). Heterogeneous CD4NKp46 ‘‘double-nega-
tive’’ ILC3s have also been described and produce IL-17A, IL-22,
IFN-g, and TNF-a and are involved in intestinal inflammation
(Buonocore et al., 2010; Klose et al., 2013; Sawa et al., 2010).
Both NKp46+ and a subset of double-negative ILC3s express
the transcription factor T-bet, which is critical for their develop-
ment (Klose et al., 2013; Rankin et al., 2013; Sciume´ et al., 2012).
More recently, GATA-3 was shown to be crucial for develop-
ment of both LTi cells and T-bet+ ILC3s (Serafini et al., 2014;
Yagi et al., 2014). ILC3s express abundant GATA-3 protein,
albeit in lower amounts than observed in mature ILC2s.
Hematopoietic chimeric mice derived from GATA-3-deficient
fetal liver cells failed to generate intestinal ILC3 subsets
and showed defective IL-22 production and maintenance of
mucosal barrier homeostasis upon infection (Serafini et al.,
2014). Conditional Gata3 ablation using Vav1-Cre generates
a similar defect in ILC3 development (Yagi et al., 2014).
Moreover, in the fetus GATA-3 is critical for differentiation of
CD135+a4b7+ CLP-like cells and cell-intrinsic GATA-3 expres-
sion is essential to generate fetal liver RORgthiIL-7Rahi precur-
sor cells (Serafini et al., 2014). Although the GATA-3-depen-
dent transcriptional pathways that drive ILC3 development
remain unclear, RNA-seq analyses revealed that GATA-3 abla-
tion does not modify Rorc, Runx1, Runx3, AhR, Id2, or Tcf7
expression in mature ILC3s (Yagi et al., 2014). This result prob-
ably reflects the context-dependent role for GATA-3 in early
ILC development that is not recapitulated in mature ILC3s,
because previous reports demonstrate that GATA-3 expres-
sion in mature Id2+ ILC3 is not essential for their homeostasis
(Hoyler et al., 2012).
GATA-3 as a Central Regulator of ILC Development
The observation that GATA-3 ablation severely affects develop-
ment of several distinct ILC subsets (ILC2s, ILC3s, intestinal
CD49a+NK1.1+ ILC1s, thymic NK cells) suggests that GATA-3
could operate at an early stage of ILC differentiation and
perhaps via the generation of common ILC precursors
(Figure 3). In the fetus, a subset of a4b7+ fetal liver precursor
(LinIL-7Ra+Sca-1intc-Kitlo) cells have been described that fail
to give rise to B and T cells but retain NK cell and ILC3 potential(Sawa et al., 2010; Yoshida et al., 2001). A similar a4b7+LinIL-
7Ra+ bone marrow subset exists, although it includes more
mature ILC2s (Hoyler et al., 2012; Klein Wolterink et al.,
2013). Recently, two reports identified that this a4b7+ subset
contains committed ILC progenitors (Constantinides et al.,
2014; Klose et al., 2014). Both groups used GFP reporter
mice (in either the Zbtb16 [PLZF] or Id2 loci) to show that
putative fetal and adult BM ILC precursors could give rise to
ILC1–ILC3 subsets in vivo and in vitro at the single-cell level.
These ILC precursors gave rise to ILC2s, ILC3s (especially
NKp46+ ILC3s), and the peculiar CD49a+NKp46+ ILC1 subset
that has been identified in the liver and gut. Interestingly, these
ILC precursors had reduced capacity to generate conventional
NK cells. As such, these ILC precursors had the developmental
potential for the same ILC subsets that require GATA-3 for their
development (Constantinides et al., 2014; Klose et al., 2013;
Rankin et al., 2013; Samson et al., 2003; Serafini et al., 2014).
Accordingly, one group found that PLZF+a4b7+ cells coex-
pressed GATA-3 protein, suggesting a link between GATA-3
expression in these ILC precursors and their cell fate potential
(Constantinides et al., 2014).
Because CLPs are GATA-3Id2 and PLZF (Constantinides
et al., 2014; Klein Wolterink et al., 2013), identifying the signals
that allow for the emergence of Id2+PLZF+GATA-3+ ILC precur-
sors from CLPs will be of considerable interest. Soluble factors
(such as IL-7) and cell-intrinsic transcription factors (including
Notch1, Tox, and Runx1) are important for the normal develop-
ment of distinct ILC subsets (Aliahmad et al., 2010; Cherrier
et al., 2012; Eberl et al., 2004; Lee et al., 2012; Rankin et al.,
2013; Tachibana et al., 2011). One possibility is that GATA-3
upregulation is an early event in CLPs that effectively restricts
B lineage fate and thereby generates T cell and ILC precursors
(Figure 3). Such ‘‘bipotent’’ precursors would then further differ-
entiate to more restricted T cell lineage precursors (ETP) or ILC
precursors; upregulation of Id2 would be a dominant factor in
promoting the development of the latter. Thismodel is consistent
with the existing data and would clearly distinguish the develop-
mental pathway of conventional NK cells (GATA-3 independent)
from other ILC subsets (GATA-3 dependent).
Although GATA-3 function in ILC precursors and ETP may
be partly overlapping, e.g., to repress B cell potential, it is
conceivable that collaboration of GATA-3 with other transcrip-
tion factors, such as RBPjk, Id2, Tcf1, Nfil3, T-bet, or RORg,
may enforce differentiation into the distinct ILC subsets or the
T cell lineage.
GATA-3 Cofactors and Target Genes
GATA-3 and Its Interacting Partners
Because GATA factors are expressed in a variety of cell types
and can act as transcriptional activators or repressors, it was
expected that their functional outcome would depend on their
interactions with other transcriptional regulators. Indeed, using
a biotinylation tagging/proteomics approach in erythroid cells,
the association of specific interacting partners were linked to
activating versus repressive functions of GATA-1 (Rodriguez
et al., 2005). Likewise, it was recently shown that GATA-3 and
chromodomain helicase DNA binding protein 4 (Chd4) complex
form functionally distinct activating and repressive assemblies
with histone acetyltransferease (HAT) and histone deacetylaseImmunity 41, August 21, 2014 ª2014 Elsevier Inc. 199
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proteins are known to interact with GATA-3 (Table 1). Genome-
wide identification of GATA-3 binding sites in thymocytes and
various effector T cell populations using ChIP-seq technology
showed that in addition to theprimary 50-(A/T)GATA(A/G)-30motif,
they contained several secondary motifs, including binding sites
for the Ets, Runx, AP1, and TCF11 transcription factors, or even
contained only secondary motifs (Wei et al., 2011). Therefore,
GATA-3 can be recruited through physical interactions with
another transcription factor or protein interactions may stabilize
binding of GATA-3 to noncanonical target sequences.
T-bet represses Th2 cell lineage commitment through a
physical interaction with GATA-3 that is enhanced by T-bet tyro-
sine phosphorylation and interferes with GATA-3 binding to its
target DNA (Hwang et al., 2005). However, recent genome-
wide comparison of T-bet and GATA-3 binding sites revealed
that many of the Th1-cell-specific GATA-3 binding sites overlap-
ped with T-bet binding motifs (Jenner et al., 2009; Kanhere et al.,
2012). As in Th1 cells, GATA-3 binds to T-box motifs and not to
cognate GATA-3 sites, and GATA-3 occupancy is mediated
through association with T-bet and T-box motifs (Kanhere
et al., 2012). On the other hand, the T-box factor Eomes interacts
with GATA-3 and suppresses the transcriptional activity of
GATA-3 (and IL-5 expression) in memory T cells (Endo et al.,
2011). Interaction of GATA-3 and the transcription factor
Runx3 actively represses production of IFN-g in Th1 cells. These
examples demonstrate how GATA-3 targets repression and can
be the target of repression.
FoxP3 forms a complex with GATA-3 specifically in activated
Treg cells. Under inflammatory settings, GATA-3 limits RORgt
expression and thus restrains excessive polarization and inflam-
matory cytokine production by Treg cells (Rudra et al., 2012;
Wohlfert et al., 2011). GATA-3 is induced upon TCR and IL-2
stimulation and is required for the accumulation of Treg cells at
inflamed sites. In Treg cells, GATA-3 specifically binds to regula-
tory elements of the Foxp3 locus and thereby directly controls
FoxP3 expression (Wang et al., 2011). Conversely, FoxP3 binds
to the promoter and intronic regions of theGata3 locus, and thus
FoxP3 and GATA-3 proteins not only physically interact, but also
reciprocally control each other’s expression. Because FoxP3-
GATA-3 complex formation is dependent on TCR stimulation,
GATA-3+ Treg cells are subject to immune control in response
to environmental changes.
YY1 occupies regulatory elements in the Th2 locus and is
required for subsequent GATA-3 binding (Hwang et al., 2013).
Thus, cooperation of YY1 with GATA-3 is essential for regulation
of the Th2 cytokine locus and Th2 cell differentiation (Table 1;
Figure 2). The Ets family member Fli1 binds to 70% of all
GATA-3-bound sites in Th2 cells (Wei et al., 2011). Upon Gata3
deletion, Fli1 occupancy at the majority of shared GATA-3 and
Fli1 binding sites is lost (including binding to the IL13 and
Rad50 loci), indicating mutualistic binding of these two factors.
The differential complex formation provides a mechanism by
which GATA-3 can be directed to a distinct subset of its potential
binding sites in a cell-type-specific fashion and can help explain
GATA-3 function as a transcriptional activator or repressor.
Moreover, context-dependent cooperative binding of GATA-3
with different transcription factors dramatically increases the
regulatory complexity. Indeed, even closely related T cell sub-200 Immunity 41, August 21, 2014 ª2014 Elsevier Inc.sets (e.g., DN2 and DP thymocytes or Th1 and Th17 effector
cells) exhibited different GATA-3 binding patterns, despite nearly
identical amounts of total GATA-3 protein present (Wei et al.,
2011; Zhang et al., 2012).
GATA-3 Target Genes
To identify GATA-3 target genes genome-wide, GATA binding
sites have been identified by ChIP-seq and changes in gene
expression upon Gata3 deletion were evaluated in various
thymocyte and mature T cell subsets (Kanhere et al., 2012;
Wei et al., 2011; Zhang et al., 2012). In these studies, >7,000
and >14,000 GATA-3 binding sites were identified genome-
wide in murine and human Th2 cells, respectively. Although
GATA-3 binding was enriched in gene regions just upstream of
transcription start sites and 50 UTR, a majority of binding sites
was >2 kb distal to known gene promoters. These distal sites
were frequently at conserved sequences, coinciding with DHS,
and enriched for both activating H3K4 methylation marks, indic-
ative for cis-regulatory elements (Kanhere et al., 2012). Gene
ontology analysis revealed that genes harboring distal GATA-3
binding sites—but not genes bound by GATA-3 only at their pro-
moter region—were enriched for immune response functions.
Upon deletion of Gata3, only a minority of GATA-3 bound genes
(<10%) showed a significant increase or decrease in expression,
but 46% of its bound genes manifested significant changes
in H3K4 or H3K27 histone methylation marks. Therefore, the
observed epigenetic modifications are most likely regulated by
GATA-3 activity and are not a consequence of transcriptional
activation or silencing.
In addition to GATA-3 targets in the Th2 locus, these genome-
wide studies identified several other complex loci controlled by
GATA-3 in Th2 cells. These include the145 kb cytokine cluster
containing the Il10 gene and the homologs Il19, Il20, and Il24
(Jones and Flavell, 2005). Consequently,Gata3 deletion resulted
in significantly decreased expression of IL-10 and IL-24.
Furthermore, the large genomic regions encompassing the che-
mokine receptor genes (CCR9, CXCR6, XCR1, CCR1, CCR3,
CCR2, CCR5, CCRL2) or the Il1r1, Il1rl2, Il1l1 (encoding IL-
33R or T1ST2), Il18r1, and Il18rap genes contains many
GATA-binding sites, whereby GATA-3 binds to sites in the
Il18r1 gene in both Th1, Th2, Th17, and iTreg cells (Kanhere
et al., 2012; Wei et al., 2011). As described above, expression
of IL-33R is crucial for ILC2 activation and enforced expression
of GATA-3 in transgenic mice induced the formation of Th2
memory cells expressing high amounts of IL-33R (Nawijn
et al., 2001a).
To date, the identification of GATA-3 targets in the various
mature ILC subsets and in developing ILCs is hampered not
only by the low cell numbers of the individual ILC subsets and
their precursors, but also by the fact that ILC precursors are still
poorly defined. Nevertheless, comparison of genes expressed in
Th2 cells and mature ILC2s showed that only 55 genes were
positively or negatively regulated by GATA-3 both in Th2 cells
and ILC2s, including Il5, Il13, Areg (encoding amphiregulin),
and Il1rl1 (Yagi et al., 2014). In contrast, 281 unique targets
were regulated by GATA-3 in ILC2s (e.g., Icos, Il2ra, and Kit),
and 568 targets were regulated in Th2 cells (e.g., Il4 and Maf).
Although these may represent both direct and indirect targets
of GATA-3, these findings indicate that GATA-3 has mostly
unique functions in these two functionally related cell types. In
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ILC2s were also regulated by GATA-3 in ILC3s.
Concluding Remarks
More than two decades of research on GATA-3 biology has
demonstrated that within the hematopoietic system, GATA-3
has multiple and diverse roles that are mediated in a complex,
dose-dependent, developmental-stage-specific, and cell-line-
age-specific fashion. Context-dependent activating or repres-
sive functions of GATA-3 are provided by differential cooperative
binding of GATA-3 with several different transcription factors,
whereby related T cell or ILC subsets exhibit very different
genome-wide GATA-3 occupancy.
Highly sensitive approaches to examine genome-wide
GATA-3 binding sites in small populations of ILC subsets and
their precursors may help to elucidate the critical GATA-3-
dependent developmental pathways from CLPs to individual
lymphocyte precursors. Moreover, such analyses should identify
crucial GATA-3 targets as well as the complex relationships be-
tween GATA-3, Notch signaling, and key transcription factors
such as Id2, RORa, RORg, Tcf1, and Nfil3 in lymphocyte cell-
fate decisions.
Parallels exist between ILC in the bone marrow and T cell
development in the thymus, as they both require—in addition
to GATA-3—similar transcription factors (e.g., Tcf-1) and Notch
signaling. Obviously, instructive signals from the microenviron-
ment such as cytokines, Notch ligands, or Wnt signaling are
different between bone marrow and thymus, but also ETP and
ILC precursors will have different intrinsic developmental capac-
ities. Therefore, future experiments should show common and
unique GATA-3 targets and their epigenetic configurations in
ILC precursors and ETP.
In mice, GATA-3 functions in a dose-dependent fashion in
both ILC2s and T cells (Klein Wolterink et al., 2013; KleinJan
et al., 2014; Nawijn et al., 2001b). Human GATA-3 haploinsuffi-
ciency affects T cell function, but its effects on ILC subsets are
not known. Enforced expression of GATA-3 during T cell devel-
opment induces DP T cell lymphoma, whereby malignant trans-
formation involves cooperation with c-Myc and the induction of
activating Notch1 mutations (van Hamburg et al., 2008). Like-
wise, recent genome-wide germline SNP analysis identified
GATA3 gene variants that influence susceptibility to Philadelphia
chromosome-positive acute lymphoblastic leukemia and risk of
relapse (Perez-Andreu et al., 2013). It will be important to under-
stand how dysregulated GATA-3 influences neoplastic transfor-
mation in hematopoietic cells and nonhematopoietic lineages
(Chou et al., 2010).
Although to date the role of GATA-3 in the regulation of Th2
cytokine expression is known in molecular detail, one of the
unresolved questions that remains is how signals from themicro-
environment cooperate to induce GATA-3 expression in acti-
vated T cells. Next to TCR, IL-4R, and Notch signaling, very
recent studies indicate that also nucleic acids (NA) released
from dead cells and complexes with antimicrobial peptides or
histones can upregulate GATA-3 expression, independently of
known NA sensors (Imanishi et al., 2014). GATA-3 expression
is sufficient and required for development and function of Th2
cells and ILC2s that play a central role in allergic inflammation.
Therefore, inhibiting GATA-3 function, e.g., by inhibition of itstranslocation to the nucleus (Maneechotesuwan et al., 2009),
could be an excellent starting point for drug discovery strategies.
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